Business Standard

Sunday, January 19, 2025 | 02:12 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Reddy's launches anti-coagulant injection in US

Product to be available in packages of 10 single-dose vials

Dr Reddy's
Premium

BS Reporter Hyderabad
Dr Reddy's Laboratories Limited announced on Tuesday that it has launched Bivalirudin injection, an anti-coagulant drug, to be available for use in 250-mg vials in the United States of America (US).

Product to be available in packages of 10 single-dose vials. 

The new drug, which is is a generic equivalent of Angiomax, has gained the approval of the US Food and Drug Administration (USFDA), thereby, its enrty in the US market. 

According to IMS health data, Angiomax brand and generic versions of the anti-coagulant drug clocked sales of approximately $198 million in US in FY17.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in